3.445USD+0.15%Mkt Cap: 144.29M USDP/E: 1.69Last update: 2026-06-01
Agenus Inc., a clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally. It offers Retrocyte Display, an antibody expression…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap144.29M USD
Enterprise Value145.06M USD
Revenue (TTM)123.87M USD
Gross Profit33.84M USD
Net Income (TTM)115.00K USD
Revenue/Share3.742 USD
Last Price3.445 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees81
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS00847G7051
Valuation
P/E (Trailing)1.69
P/E (Forward)-1.52
PEG1.44
EV/EBITDA9.55
EV/Revenue1.17
P/S1.18
P/B-0.61
EPS (TTM)2.05
EPS (Forward)-2.30
52W Range
2.71016% of range7.340
52W High7.340 USD
52W Low2.710 USD
Profitability
Gross Margin29.63%
Oper. Margin44.62%
EBITDA Margin12.26%
Profit Margin0.10%
ROE-0.04%
ROA0.05%
Growth
Revenue Growth40.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-77.19M USD
CapEx (TTM)6.00K USD
FCF Margin-40.88%
FCF Yield-35.10%
Net Debt6.08M USD
Net Debt/EBITDA0.40
Balance Sheet
Debt/Equity-0.21
Current Ratio0.38
Quick Ratio0.36
Book Value/Sh-5.7430 USD
Cash/Share0.8400 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateApr 12, 2024
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)15.50 USD
Target Range8.000 USD – 23.00 USD
# Analysts2
Ownership
Shares Out.41.64M
Float38.63M
Insiders6.69%
Institutions23.48%
Short Interest
Short Ratio5.7d
Short % Float12.93%
Short % Out.12.77%
Shares Short5.32M
Short (prev mo.)4.35M
Technical
SMA 503.762 (-8.4%)
SMA 2003.824 (-9.9%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)812.80K
Avg Vol (10d)631.15K
Technical Indicators
RSI (14)47.2
MACD-0.1431
MACD Signal-0.1529
MACD Hist.+0.0098
BB Upper4.145 USD
BB Middle3.502 USD
BB Lower2.859 USD
BB Width36.72%
ATR (14)0.2669 USD
Vol Ratio (20d)0.58x